Vir Biotechnology, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | -29K | 64.1M | 240K | 1.2M | 3.0M | 12.4M | 2.4M | 3.1M |
| Cost of Goods Sold | 2.8M | -366.6M | 151.5M | 97.5M | 117.6M | 88.8M | 195.2M | 105.2M |
| Gross Profit | -2.8M | 430.6M | -151.2M | -96.3M | -114.6M | -76.4M | -192.8M | -102.1M |
| R&D Expenses | 108.9M | 88.3M | 151.5M | 97.5M | 118.6M | 106.1M | 195.2M | 105.1M |
| Operating Expenses | 130.3M | 467.2M | 22.2M | 22.1M | 25.0M | 40.7M | 38.5M | 56.5M |
| Operating Income | -133.2M | -36.6M | -173.4M | -118.4M | -139.5M | -117.2M | -231.3M | -158.6M |
| Other Income / Gains | 7.7M | -6.4M | 10.5M | 7.6M | 18.6M | 12.5M | 17.8M | 18.7M |
| Net Income | -125.7M | -42.9M | -163.1M | -111.0M | -121.0M | -104.6M | -213.7M | -138.4M |
| EPS (Diluted) | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 | -0.76 | -1.56 | -1.02 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 97.931 | 6.721 | -630.05 | -79.329 | -37.791 | -6.175 | -81.029 | -33.20 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 23.3M | 23.6M | 22.2M | 0 | 0 | 0 | 0 | 0 |
| Other Expenses | -1.9M | 355.3M | -151.5M | -75.4M | -93.7M | -65.3M | -156.7M | -48.6M |
| Cost And Expenses | 133.2M | 100.7M | 173.7M | 119.6M | 142.6M | 129.5M | 233.7M | 161.7M |
| Interest Income | 7.2M | 7.8M | 9.4M | 10.8M | 12.3M | 14.2M | 17.5M | 18.8M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 2.8M | 2.9M | 3.0M | 2.9M | 2.9M | 2.9M | 2.9M | 4.3M |
| Ebitda | -130.4M | -40.2M | -160.0M | -115.7M | -135.7M | -100.2M | -215.7M | -128.1M |
| Ebitdaratio | 4K | -0.627 | -666.563 | -95.282 | -44.743 | -8.10 | -90.629 | -41.657 |
| Operating Income Ratio | 5K | -0.571 | -722.679 | -97.543 | -46.025 | -9.467 | -97.187 | -51.587 |
| Income Before Tax | -125.5M | -43.1M | -163.0M | -110.8M | -120.9M | -104.7M | -213.5M | -139.9M |
| Income Before Tax Ratio | 4K | -0.672 | -679.054 | -91.259 | -39.891 | -8.459 | -89.723 | -45.493 |
| Income Tax Expense | 170K | -137K | 168K | 170K | 16K | -86K | 177K | -1.5M |
| Net Income Ratio | 4K | -0.67 | -679.754 | -91.399 | -39.896 | -8.452 | -89.797 | -45.001 |
| Epsdiluted | -0.85 | -0.31 | -1.17 | -0.80 | -0.88 | -0.76 | -1.56 | -1.02 |
| Weighted Average Shs Out | 147.4M | 139.2M | 138.9M | 138.4M | 137.5M | 136.8M | 136.7M | 136.2M |
| Weighted Average Shs Out Dil | 147.4M | 139.2M | 138.9M | 138.4M | 137.5M | 136.8M | 136.7M | 136.2M |